Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection

Author(s):  Allen Loyd V Jr

Issue:  Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide
View All Articles in Issue

Abstract:  A formulation for preparing Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, panitumumab, cancer, recombinant human monoclonal antibody, epidermal growth factor receptor, antineoplastic agent

Related Categories: CANCER AND AIDS, EAR NOSE THROAT, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=3199

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products